Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion type Assertion NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_head.
- NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_provenance.
- NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion evidence source_evidence_literature NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_provenance.
- NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion SIO_000772 19459784 NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_provenance.
- NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion wasDerivedFrom befree-20140225 NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_provenance.
- NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion wasGeneratedBy ECO_0000203 NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_provenance.